论文部分内容阅读
充血性心力衰竭(心衰)病人的现代治疗目的在于通过降低前后负荷,增强正性肌力收缩或两者兼之,改善泵功能,防止水钠潴留,提高生命质量和生存率。通过常规治疗,包括限钠、洋地黄制剂、利尿剂和非特异性血管扩张剂,取得不同程度疗效。然而,尽管采取上述治疗措施,仍有许多病人症状不能缓解。自血管紧张素转化酶(ACE)抑制剂应用于临床以来,显示出除改善心衰症状以外,提高了生存率。
The modern treatment of patients with congestive heart failure (CHF) aims to improve pump function, prevent water and sodium retention, improve quality of life and survival by reducing antecedent and postload, enhancing positive inotropic contractions or both. Through conventional treatment, including sodium limit, digitalis preparations, diuretics and non-specific vasodilators, to obtain varying degrees of efficacy. However, despite the above treatment, many patients still have symptoms that can not be alleviated. Since angiotensin converting enzyme (ACE) inhibitors have been clinically used, they have been shown to improve survival in addition to improving heart failure symptoms.